Calvert Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Calvert Investment Management's GILD Position: Q1 2017 in Review
Calvert Investment Management sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 175,224 shares — an estimated $12.5M sold.
Calvert Investment Management first reported a position in GILD in Q2 2013 and held it in 15 quarters. The position peaked at $26.9M in Q4 2015. 1,524 funds tracked by Wall St. Rank hold GILD as of Q1 2017.
- Calvert Investment Management reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
- Calvert Investment Management sold 175,224 Gilead Sciences shares in Q1 2017, an estimated $12.5M.
- Calvert Investment Management first reported a position in Gilead Sciences in Q2 2013 and held it in 15 quarters.
- Calvert Investment Management's Gilead Sciences position peaked at $26.9M in Q4 2015.
- 1,524 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.
Based on Calvert Investment Management's 13F filing for Q1 2017.